Pulmonx (LUNG) Cash & Current Investments (2019 - 2025)
Pulmonx (LUNG) posted quarterly Cash & Current Investments of $69.8 million for Q4 2025, down 31.27% year-over-year from $101.5 million in Q4 2024, and down 8.88% quarter-over-quarter from $76.5 million in Q3 2025.
Pulmonx (LUNG) Cash & Current Investments (2019 - 2025) Analysis & Trends
Pulmonx (LUNG) has reported Cash & Current Investments for 7 consecutive years, with $69.8 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Cash & Current Investments fell 31.27% year-over-year to $69.8 million; the TTM figure through Dec 2025 stood at $69.8 million (down 31.27% YoY), while the FY2025 annual figure was $69.8 million, down 31.27% from the prior year.
- Cash & Current Investments fell to $69.8 million in Q4 2025 per LUNG's latest filing, from $76.5 million in the prior quarter.
- Across five years, Cash & Current Investments topped out at $219.1 million in Q1 2021 and bottomed at $69.8 million in Q4 2025.
- Historically, Cash & Current Investments has averaged $136.0 million across 5 years, with a median of $126.1 million in 2023.
- Annual changes were most pronounced in 2021 — Cash & Current Investments jumped 1248.85% — and 2025, when it plunged 31.27%.
- Pulmonx's Cash & Current Investments stood at $180.0 million in 2021, then slipped by 21.61% to $141.1 million in 2022, then retreated by 17.03% to $117.1 million in 2023, then dropped by 13.34% to $101.5 million in 2024, then slumped by 31.27% to $69.8 million in 2025.
- Business Quant data shows LUNG's Cash & Current Investments at $69.8 million in Q4 2025, $76.5 million in Q3 2025, and $84.2 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn | 5.60 Bn |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn | 3.48 Bn |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn | 4.25 Bn |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | 1.95 Bn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 3.32 Bn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 482.30 Mn |
| 10 | Pulmonx | 93.95 Mn | 24.20 Mn | - | 69.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 69.75 Mn |
| Sep 30, 2025 | 76.55 Mn |
| Jun 30, 2025 | 84.23 Mn |
| Mar 31, 2025 | 88.70 Mn |
| Dec 31, 2024 | 101.48 Mn |
| Sep 30, 2024 | 107.78 Mn |
| Jun 30, 2024 | 114.55 Mn |
| Mar 31, 2024 | 116.13 Mn |
| Dec 31, 2023 | 117.10 Mn |
| Sep 30, 2023 | 116.48 Mn |
| Jun 30, 2023 | 135.15 Mn |
| Mar 31, 2023 | 152.84 Mn |
| Dec 31, 2022 | 141.14 Mn |
| Sep 30, 2022 | 156.90 Mn |
| Jun 30, 2022 | 162.09 Mn |
| Mar 31, 2022 | 170.08 Mn |
| Dec 31, 2021 | 180.04 Mn |
| Sep 30, 2021 | 199.85 Mn |
| Jun 30, 2021 | 209.48 Mn |
| Mar 31, 2021 | 219.07 Mn |